Skip to main content

Find Clinical Trials

Home
Conditions
Substance-Related Disorders

Clinical trial condition

Substance-Related Disorders

Explore clinical trials studying Substance-Related Disorders. Study availability and eligibility vary by location and protocol.

4,198 public trials 567 recruiting studies

Refine in advanced search Browse all conditions

Substance-Related Disorders trial results

Completed

ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent Adults

NCT00156923

Conditions: Alcohol-Related Disorders, Alcoholism, Chemically-Induced Disorders, +2 more
Locations: Not specified

View Trial Details

Completed

ALK21-003: Study of Medisorb® Naltrexone (VIVITROL®) in Alcohol-Dependent Adults

NCT01218958

Conditions: Alcohol-Related Disorders, Alcoholism, Chemically-Induced Disorders, +2 more
Locations: Not specified

View Trial Details

Completed

ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults

NCT00511836

Conditions: Alcohol Dependence, Alcohol-Related Disorders, Alcoholism, +7 more
Locations: McLean Hospital Belmont, Massachusetts, United States

View Trial Details

Completed

Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals

NCT00249483

Conditions: Chemically-Induced Disorders, Cocaine-Related Disorders, Mental Disorders, +1 more
Locations: New York State Psychiatric Institute New York, United States

View Trial Details

Completed

Behavior and Driving Safety Study II

NCT01270217

Conditions: Alcohol-Related Disorders, Alcoholic Intoxication, Behavior, +6 more
Locations: Sacramento County Main Jail Sacramento, California, United States

View Trial Details

Completed

Survey on the Place of Community Pharmacists in the Detection of Cannabis Use: a Student's Point of View

NCT03167021

Conditions: Cannabis Use, Chemically-Induced Disorders, Marijuana Abuse, +2 more
Locations: CHU Clermont-Ferrand Clermont-Ferrand, Auvergne, France

View Trial Details

Completed

Medications Development for Drug Abuse Disorders

NCT01188421

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +5 more
Locations: Johns Hopkins University (BPRU) Bayview Campus Baltimore, Maryland, United States

View Trial Details

Completed

PET Imaging of DHA Metabolism

NCT00074503

Conditions: Alcohol-Related Disorders, Alcoholism, Chemically-Induced Disorders, +3 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Quantitation of Human Cerebral Nicotinie Receptors With 2[18F]FA-85380 and PET Healthy Non-smokers and Ex-Smokers and in Heavy and Light Situational Smokers

NCT01038245

Conditions: Behavior, Chemically-Induced Disorders, Mental Disorders, +4 more
Locations: National Institute on Drug Abuse, Biomedical Research Center (BRC) Baltimore, Maryland, United States

View Trial Details

Completed

OPRM1 A118G SNP, Alcohol Response, and Striatal Dopamine

NCT00401999

Conditions: Alcohol-Related Disorders, Alcoholism, Chemically-Induced Disorders, +2 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details